G-Rex bioreactors incubated in Heracell™ Vios™ CR CO2 Incubators help prevent cross contamination and bacterial contamination in cell and gene modified cell therapy production

Cell & Gene Therapy Insights 2024; 10(4), 593–607

DOI: 10.18609/cgti.2024.072

Published: 12 June
Innovator Insight
Mary Kay Bates, Dan Fick, Jϋrgen Schneider, Dan Welch, Josh Ludwig

Abstract: for cell and gene modified cell therapy (GMCT) manufacturing, a robust contamination control strategy (CCS) is necessary to ensure compliance with current good manufacturing practices (cGMP). A successful CCS helps ensure safety, purity, efficacy, and quality of a cell therapy product. Cell therapy manufacturers should implement closed systems (CS) wherever possible and employ equipment that maintains a stable, clean environment with advanced monitoring. We show that CS G-Rex® bioreactors combined with Thermo Scientific™ Heracell™ Vios™ CR carbon dioxide (CO2) incubators enable simplified parallel processing capabilities and significantly reduced contamination risks in a highly efficient production. Producing T cells, NK cells and others in a CS G-Rex bioreactor (Wilson Wolf Manufacturing, LLC) reduces the risk of contamination. The G-Rex approach eliminates most manual handling, a leading source of contamination. G-Rex bioreactors include weldable tubing for simple CS sterile connections and do not require interventions for feeding. Importantly, CS G-Rex bioreactors feature a validated sterile fluid path that reliably maintains integrity throughout manufacturing as shown by microbial ingress testing based on ASTM E-3251. The bioreactors withstand full immersion in a challenge media solution containing bacteria for at least 14 days. G-Rex bioreactors also passed Viral Penetration testing based on ASTM Method F1671, demonstrating suitability for use in CAR-T and other CGT applications requiring use of virus. Heracell Vios CR CO2 Incubators provide recovery of all parameters in 10 minutes or less, and uniformity of ±0.3 ˚C per DIN 12880, which defines how incubators and other laboratory heating equipment should be measured. These parameters are maintained even when performing high volume production with ten G-Rex 500M-CS bioreactors simultaneously. Thermo Scientific™ CultiMaxx™ shelving maximizes production capacity per footprint. Incubating multiple G-Rex bioreactors in a single chamber means the incubator must offer proven contamination control features, to protect individual donor/patient product, if applicable. An on-demand cycle delivers 12-log sterility assurance level (SAL). In-chamber HEPA filtration generates air cleanliness in the chamber equal to ISO Class 5. Data show the Heracell Vios CR CO2 incubators are certified for use in ISO Class 5, GMP Grade A/B cleanrooms. Together, G-Rex bioreactors incubated in Heracell Vios CR CO2  incubators offer a high yield, parallel processing method with reduced contamination risk in a highly efficient footprint enabling robust CCS in a cGMP environment.